RIO DE JANEIRO, BRAZIL - A research group from the School of Medicine and Pharmaceutical Sciences of the University of São Paulo (USP) is excited about the development of a Brazilian vaccine in nasal spray format to immunize people against the novel coronavirus.
In its latest trials, the results of the formula developed by USP in partnership with the Heart Institute (InCor) were positive. Should all proceed as planned, the vaccine . . .